Scenarios that move ALLO

Allogene Therapeutics, Inc. - Common Stock

Scenarios that move ALLO: 2 analyses, 0 positive, 2 negative.

1. 2026-10-07 · SRX Global SPV agrees to acquire CERo Therapeutics — ▼ · impact -10 · confidence low · horizon quarters
2. 2026-10-05 · Genmab and AbbVie report positive epcoritamab lymphoma trial results — ▼ · impact -38 · confidence low · horizon weeks

All scenarios · Run a scenario · Pricing